{"abstract":"The Food and Drug Administration (FDA or Agency) is announcing a public meeting and an opportunity for public comment on patient- focused drug development for breast cancer. Patient-focused drug development is part of FDA's performance commitments made as part of the fifth authorization of the Prescription Drug User Fee Act (PDUFA V). The public meeting is intended to allow FDA to obtain patient perspectives on the impact of breast cancer on daily life and patient views on treatment approaches.","action":"Notice of public meeting; request for comments.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2014/12/19/2014-29721.html","cfr_references":[],"citation":"79 FR 75822","comment_url":null,"comments_close_on":"2015-06-02","correction_of":null,"corrections":[],"dates":"The public meeting will be held on April 2, 2015, from 1 p.m. to 5 p.m. Registration to attend the meeting must be received by March 23, 2015 (see SUPPLEMENTARY INFORMATION for instructions). Submit electronic or written comments to the public docket by June 2, 2015.","disposition_notes":null,"docket_ids":["Docket No. FDA-2014-N-2137"],"dockets":[{"supporting_documents":[],"agency_name":null,"documents":[{"comment_count":20,"comment_start_date":"2014-12-19","updated_at":"2023-03-01T13:16:46.736-05:00","comment_url":"https://www.regulations.gov/commenton/FDA-2014-N-2137-0001","allow_late_comments":null,"id":"FDA-2014-N-2137-0001","comment_end_date":"2015-06-03","regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2014-N-2137","title":"Public Meeting on Patient-Focused Drug Development for Breast Cancer"}],"document_number":"2014-29721","effective_on":null,"end_page":75824,"executive_order_notes":null,"executive_order_number":null,"explanation":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2014/12/19/2014-29721.xml","html_url":"https://www.federalregister.gov/documents/2014/12/19/2014-29721/public-meeting-on-patient-focused-drug-development-for-breast-cancer-request-for-comments","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2014-29721?publication_date=2014-12-19","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2014-12-19/2014-29721/mods.xml","not_received_for_publication":null,"page_length":3,"page_views":{"count":368,"last_updated":"2026-04-10 04:15:05 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2014-12-19/pdf/2014-29721.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2014-29721.pdf?1418910576","publication_date":"2014-12-19","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2014/12/19/2014-29721.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_count":20,"agency_id":"FDA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2014-N-2137","supporting_documents_count":0,"docket_id":"FDA-2014-N-2137","document_id":"FDA-2014-N-2137-0001","regulation_id_number":null,"title":"Public Meeting on Patient-Focused Drug Development for Breast Cancer","checked_regulationsdotgov_at":"2023-03-01T18:16:45Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":75822,"subtype":null,"title":"Public Meeting on Patient-Focused Drug Development for Breast Cancer; Request for Comments","toc_doc":"Patient-Focused Drug Development for Breast Cancer","toc_subject":"Meetings:","topics":[],"type":"Notice","volume":79}